Literature DB >> 9165136

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation.

O Hansen1, J Overgaard, H S Hansen, M Overgaard, M Höyer, K E Jörgensen, L Bastholt, A Berthelsen.   

Abstract

PURPOSE: Accelerated repopulation of tumor cells during radiotherapy has been suggested as an important cause of treatment failure in squamous cell carcinoma of the head and neck. Due to tumor heterogeneity, not all tumors may benefit from accelerated radiotherapy at the expense of a lower total dose. This analysis evaluates the impact of histological differentiation on loco-regional control in relation to treatment duration. PATIENTS AND METHODS: A total of 501 patients with advanced supraglottic and pharyngeal squamous cell carcinoma with known histopathological grading were treated with planned split-course (191 patients) or continuous radiotherapy (310 patients) in two consecutive randomized controlled trials. Irradiation was given 2 Gy per fraction, 5 fractions per week to a dose of 66-68 Gy in 9.5 or 6.5 weeks, respectively.
RESULTS: Overall, split-course and continuous treatment resulted in a 5-year loco-regional control of 30% and 41% (P = 0.007), respectively. However, the detrimental effects of split-course were only found in moderately and well-differentiated tumors, where the 5-year tumor controls were 38% and 21% after continuous and split-course treatment, respectively (P = 0.001). In contrast, in poorly differentiated tumors loco-regional control was obtained in 44% of the cases for continuous and 40% for split-course treatment (P = 0.63).
CONCLUSIONS: It is suggested that the ability to accelerate repopulation may be lost by dedifferentiation, and that prolongation of the overall treatment time only lead to reduced loco-regional control in well to moderately differentiated tumors.

Entities:  

Mesh:

Year:  1997        PMID: 9165136     DOI: 10.1016/s0167-8140(97)01904-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  25 in total

Review 1.  Altered fractionation in the treatment of head and neck cancer.

Authors:  K S Hu; L B Harrison
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

2.  A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.

Authors:  Tomoya Yokota; Satoshi Hamauchi; Yukio Yoshida; Takashi Yurikusa; Miho Suzuki; Aiko Yamashita; Hirofumi Ogawa; Tsuyoshi Onoe; Keita Mori; Tetsuro Onitsuka
Journal:  Support Care Cancer       Date:  2018-04-07       Impact factor: 3.603

3.  [Prevention and therapy of acute radiation injuries of the skin and mucosa. I. Results of a German multicenter questionnaire].

Authors:  J S Zimmermann; R Wilhelm; P Niehoff; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

4.  Atypical cell populations associated with acquired resistance to cytostatics and cancer stem cell features: the role of mitochondria in nuclear encapsulation.

Authors:  David Díaz-Carballo; Sebastian Gustmann; Holger Jastrow; Ali Haydar Acikelli; Philip Dammann; Jacqueline Klein; Ulrike Dembinski; Walter Bardenheuer; Sascha Malak; Marcos J Araúzo-Bravo; Beate Schultheis; Constanze Aldinger; Dirk Strumberg
Journal:  DNA Cell Biol       Date:  2014-08-15       Impact factor: 3.311

Review 5.  3D conformal hypofractionated radical radiotherapy in early glottic cancer.

Authors:  Ana Cristina Amado; Laurentiu Bujor; Isabel Monteiro Grillo
Journal:  Rep Pract Oncol Radiother       Date:  2013-05-30

6.  Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis.

Authors:  Imjai Chitapanarux; Tharatorn Tungkasamit; Janjira Petsuksiri; Danita Kannarunimit; Kanyarat Katanyoo; Chakkapong Chakkabat; Jiraporn Setakornnukul; Somying Wongsrita; Naruemon Jirawatwarakul; Chawalit Lertbusayanukul; Patumrat Sripan; Patrinee Traisathit
Journal:  Support Care Cancer       Date:  2017-09-23       Impact factor: 3.603

Review 7.  How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

Authors:  Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-31       Impact factor: 2.503

8.  Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.

Authors:  Sabrina Falkowski; Patrick Trouillas; Jean-Luc Duroux; Jean-Marie Bonnetblanc; Pierre Clavère
Journal:  Support Care Cancer       Date:  2009-12-09       Impact factor: 3.603

9.  Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.

Authors:  Natalie M Lowe; Jonathan M Bernstein; Kathleen Mais; Kate Garcez; Lip W Lee; Andrew Sykes; David J Thomson; Jarrod J Homer; Catharine M West; Nicholas J Slevin
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-08       Impact factor: 4.553

10.  Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.

Authors:  Jürg Kutter; Mahmut Ozsahin; Philippe Monnier; Roger Stupp
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.